Showing results (1-10 of 549) with videos related to

Sort By:
Pageof 55
Tumori|April 30, 1988
Phase II study with ifosfamide in advanced malignant melanomaE Negretti, L Ferrari, V Bonfante, et al.
Cancer Treatment Reports|December 1, 1986
Cytarabine and cisplatin in advanced malignant melanomaE Bajetta, C Verusio, V Bonfante, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1990
Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remissionS Viviani, A Santoro, E Negretti, et al.
Investigational New Drugs|January 1, 1983
Phase I study of 4-demethoxydaunorubicinV Bonfante, L Ferrari, F Villani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2002
Clinical significance of blood chromogranin A measurement in neuroendocrine tumoursE Seregni, L Ferrari, E Bajetta, et al.
Anticancer Research|January 12, 2000
The biological characteristics of chromogranin A and its role as a circulating marker in neuroendocrine tumoursL Ferrari, E Seregni, E Bajetta, et al.
Tumori|October 31, 1984
Monoclonal gammopathy (IgM-k) in a patient with Burkitt's type lymphoblastic lymphomaE Bajetta, G Gasparini, G Facchetti, et al.
Digestion|January 1, 1996
The role of somatostatin analogues in the treatment of gastro-enteropancreatic endocrine tumoursE Bajetta, C Carnaghi, L Ferrari, et al.
American Journal of Clinical Oncology|August 1, 1988
Cyclophosphamide, adriamycin, and cis-platinum (CAP) in metastatic and locally advanced breast cancerC Verusio, E Bajetta, L Ferrari, et al.
Expert Review of Anticancer Therapy|July 13, 2002
Advances in diagnosis and therapy of neuroendocrine tumorsE Bajetta, G Procopio, R Buzzoni, et al.
Pageof 55